胺用于术后避免抑郁症状:K-PASS可行性随机试验
Bradley A Fritz1, Bethany R Tellor Pennington1, Catherine Dalton1
1Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.
这项研究探讨了治疗术后抑郁症的胺注,发现招募和评估是可行的. 虽然胺显示出减轻症状的趋势,但需要进一步的研究来确认抑郁症手术患者的疗效.
科学领域:
- 麻醉学和外科手术期间的医学.
- 精神病学和心理健康 精神病学和心理健康
- 临床试验设计和可行性
背景情况:
- 患有抑郁病史的患者有患术后抑郁症状的高风险.
- 测试持续胺注射来控制这些症状的可行性需要研究.
研究的目的:
- 确定一个安慰剂对照试验的可行性,评估持续的胺输液治疗术后抑郁症状.
- 为了评估患者招募,治疗管理和结果测量在这个人群中.
主要方法:
- 单中心,三重盲目,安慰剂控制的随机临床试验.
- 成年患有抑郁症的患者接受住院手术后接受胺 (0.5毫克/千克,然后0.3毫克/千克/小时3小时) 或液安慰剂手术后.
- 通过随机化率,输液完成和评估完成来评估可行性;用蒙哥马利-阿斯伯格抑郁症评分表来衡量抑郁症状.
主要成果:
- 31%的接触患者被随机分配 (1.5周后的协议变化).
- 94%的患者完成了研究输液,89%的抑郁症评估完成了.
- 在胺和安慰剂组中,抑郁症状的中位数下降,两组之间没有显著的持续差异.
结论:
- 患者招募,药物管理和结果测量是可行的,保持盲目.
- 结果表明,需要进行一项全面的试验,调查胺对手术后抑郁症的作用.
更多相关视频
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
10:32A Guide to In vivo Single-unit Recording from Optogenetically Identified Cortical Inhibitory Interneurons
Published on: November 7, 2014
相关概念视频
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Depolarizing Blockers: Pharmocokinetics
